| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000027785 |
| Receipt No. | R000031827 |
| Scientific Title | Prospective study on prognosis and diagnosis of gallbladder cancer. |
| Date of disclosure of the study information | 2017/07/07 |
| Last modified on | 2019/03/24 (Ver. 8) |
| Basic information | ||
| Public title | Prospective study on prognosis and diagnosis of gallbladder cancer. | |
| Acronym | GALLOP study | |
| Scientific Title | Prospective study on prognosis and diagnosis of gallbladder cancer. | |
| Scientific Title:Acronym | GALLOP study | |
| Region |
|
|
| Condition | ||
| Condition | Gallbladder cancer
(Including cystic duct carcinoma) |
|
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | For gallbladder cancer, candidate optimal treatment policies derived from diagnosis time information are clarified by prospective observational research. |
| Basic objectives2 | Others |
| Basic objectives -Others | In this study, clinical staging is registered at the time of diagnosis of gallbladder cancer, and the subsequent treatment, surgical resection, pathology result, prognosis are analyzed positively.
Comparing prognosis and optimal treatment based on the diagnosis at the time of treatment decision can not be searched by retrospective research after grasping the curiosity of prognosis and surgery. |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Others |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Overall survival |
| Key secondary outcomes | Relapse free survival
Adverse event occurrence rate Serious adverse event (adverse reaction) incidence Complication incidence, severity and type of surgery ,chemotherapy, radiation therapy, other treatments The 30-day mortality rate The 90-day mortality rate |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Conditions diagnosed as gallbladder cancer and cystic duct carcinoma by diagnostic imaging before the commencement of treatment
2. Age at registration is over 20 years old |
|||
| Key exclusion criteria | 1. Patients who can not photograph either contrast CT or simple MRI
2. Patients judged unsuitable as subjects by the attending physician |
|||
| Target sample size | 200 | |||
| Research contact person | |||||||
| Last name of lead principal investigator |
|
||||||
| Organization | Tohoku University Graduate School of Medicine | ||||||
| Division name | Department of Surgery | ||||||
| Zip code | 980-8574 | ||||||
| Address | 1-1, Seiryo-machi, Aoba-ku, Sendai | ||||||
| TEL | 022-717-7205 | ||||||
| kein_h11@surg1.med.tohoku.ac.jp | |||||||
| Public contact | |||||||
| 1st name of contact person |
|
||||||
| Organization | Tohoku University Hospital | ||||||
| Division name | Department of Surgery | ||||||
| Zip code | 980-8574 | ||||||
| Address | 1-1, Seiryo-machi, Aoba-ku, Sendai | ||||||
| TEL | 022-717-7205 | ||||||
| Homepage URL | |||||||
| gbjimu@surg.med.tohoku.ac.jp | |||||||
| Sponsor | |
| Institute | Japan Biliary Association |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Self funding |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Clinical Research Review Board, Tohoku University School of Medicine |
| Address | 2-1, Seiryo-machi, Aoba-ku, Sendai |
| Tel | 022-717-8007 |
| med-kenkyo@grp.tohoku.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Cohort case-control study |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031827 |